Forty years of anti-D immunoprophylaxis.
作者信息
Reali Giorgio
出版信息
Blood Transfus. 2007 Jan;5(1):3-6. doi: 10.2450/2007.0b18-06.
Abstract
摘要
相似文献
1
Forty years of anti-D immunoprophylaxis.四十年的抗-D免疫预防
Blood Transfus. 2007 Jan;5(1):3-6. doi: 10.2450/2007.0b18-06.
2
Rh Immunoprophylaxis for Women With a Serologic Weak D Phenotype.具有血清学弱D表型女性的Rh免疫预防
Lab Med. 2015 Summer;46(3):190-4. doi: 10.1309/LMUNUP4FJTUX2GCD.
3
[Anti-D sensitizations in the Leipzig District recorded in 1980 and 1981 and their relation to IgG-anti-D(Rh0) immunoprophylaxis].[1980年和1981年莱比锡地区记录的抗-D致敏反应及其与IgG抗-D（Rh0）免疫预防的关系]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(1):133-45.
4
Mycobacterium indicus pranii vaccine immunoprophylaxis in anti-phenolic glycolipid-1-positive leprosy contacts - A pilot study from a tertiary care center in North India.印度分枝杆菌疫苗免疫预防抗苯丙氨酸二醇脂质 1 阳性麻风接触者 - 来自印度北部一家三级保健中心的初步研究。
Indian J Dermatol Venereol Leprol. 2021 Jan-Feb;88(1):47-50. doi: 10.25259/IJDVL_882_18.
5
[Justification of the need to normalize vitamin D status for immunoprophylaxis].[免疫预防中维生素D状态正常化必要性的理由]
Vopr Pitan. 2020;89(6):70-81. doi: 10.24411/0042-8833-2020-10080. Epub 2020 Nov 20.
6
[Effectiveness of immunoprophylaxis in negative Rhesus factor].[恒河猴阴性因子免疫预防的有效性]
Ginekol Pol. 2000 Aug;71(8):859-62.
7
The effect of different immunoprophylaxis regimens on post-transplant cytomegalovirus (CMV) infection in CMV-seropositive liver transplant recipients.不同免疫预防方案对巨细胞病毒（CMV）血清学阳性肝移植受者移植后巨细胞病毒感染的影响。
Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12736. Epub 2017 Aug 7.
8
Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure.改进免疫接种对乙型肝炎病毒母婴传播的保护作用及与免疫预防失败相关的危险因素
Medicine (Baltimore). 2016 Aug;95(34):e4390. doi: 10.1097/MD.0000000000004390.
9
Expression of CXCL10 (IP-10) and CXCL11 (I-TAC) chemokines during Mycobacterium tuberculosis infection and immunoprophylaxis with Mycobacterium indicus pranii (Mw) in guinea pig.在豚鼠感染结核分枝杆菌和用印度分枝杆菌（Mw）免疫预防过程中 CXCL10（IP-10）和 CXCL11（I-TAC）趋化因子的表达。
Infect Genet Evol. 2013 Jan;13:11-7. doi: 10.1016/j.meegid.2012.10.002. Epub 2012 Oct 27.
引用本文的文献
1
Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.不同抗 D 免疫球蛋白策略预防 Rh 溶血病胎儿和新生儿的临床价值：网状荟萃分析。
PLoS One. 2020 Mar 12;15(3):e0230073. doi: 10.1371/journal.pone.0230073. eCollection 2020.
2
Predicting anti-RhD titers in donors: Boostering response and decline rates are personal.预测供者的抗 RhD 效价：增强反应和下降速率因人而异。
PLoS One. 2018 Apr 26;13(4):e0196382. doi: 10.1371/journal.pone.0196382. eCollection 2018.
3
Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.抗原密度决定红细胞输血后的免疫反应性。
J Immunol. 2017 Apr 1;198(7):2671-2680. doi: 10.4049/jimmunol.1601736. Epub 2017 Mar 1.
4
Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.胎儿/新生儿同种免疫性血小板减少症：发病机制、诊断与预防
Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):279-90. doi: 10.1007/s00005-015-0371-9. Epub 2015 Nov 12.
5
Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.意大利新生儿溶血病的预防与发病率调查。
Blood Transfus. 2013 Oct;11(4):518-27. doi: 10.2450/2013.0179-12. Epub 2013 Jun 14.
6
Cytometry and Rhesus: not only for haemolytic disease of the newborn.血细胞计数与恒河猴：不仅用于新生儿溶血病。
Blood Transfus. 2011 Jan;9(1):104-6. doi: 10.2450/2010.0027-10. Epub 2010 Sep 14.
本文引用的文献
1
A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy.意大利抗 D 免疫预防的应用现状及新生儿溶血病发生率的调查。
Blood Transfus. 2007 Jan;5(1):7-14. doi: 10.2450/2007.0018-06.
2
Treatment of Severe Erythroblastosis by Simultaneous Removal and Replacement of the Blood of the Newborn Infant.通过同时去除和替换新生儿血液治疗严重新生儿溶血病
Science. 1946 May 10;103(2680):583-4. doi: 10.1126/science.103.2680.583.
3
Controlled trials of the treatment of haemolytic disease of the newborn.新生儿溶血病治疗的对照试验。
Lancet. 1952 Mar 1;1(6705):429-33. doi: 10.1016/s0140-6736(52)91949-1.
4
Current status of immunoprophylaxis with anti-D immunoglobin.抗 D 免疫球蛋白免疫预防的现状
Vox Sang. 2003 Nov;85(4):328-37. doi: 10.1111/j.0042-9007.2003.364_1.x.
5
SUCCESSFUL PREVENTION OF EXPERIMENTAL RH SENSITIZATION IN MAN WITH AN ANTI-RH GAMMA2-GLOBULIN ANTIBODY PREPARATION: A PRELIMINARY REPORT.用抗Rhγ2球蛋白抗体制剂成功预防人体实验性Rh致敏：初步报告
Transfusion. 1964 Jan-Feb;4:26-32. doi: 10.1111/j.1537-2995.1964.tb02824.x.
6
Experimental studies on the prevention of Rh haemolytic disease.预防Rh溶血病的实验研究。
Br Med J. 1961 May 27;1(5238):1486-90. doi: 10.1136/bmj.1.5238.1486.
7
The influence of the ABO system on Rh hemolytic disease.ABO系统对Rh溶血病的影响。
Hum Biol. 1958 Feb;30(1):14-28.
8
[Demonstration of fetal hemoglobin in erythrocytes of a blood smear].[血涂片红细胞中胎儿血红蛋白的显示]
Klin Wochenschr. 1957 Jun 15;35(12):637-8. doi: 10.1007/BF01481043.
9
Molecular biology of partial D and weak D: implications for blood bank practice.部分D和弱D的分子生物学：对血库实践的影响
Clin Lab. 2002;48(1-2):53-9.
10
Statement from the consensus conference on anti-D prophylaxis. 7 and 8 April 1997. The Royal College of Physicians of Edinburgh. The Royal College of Obstetricians and Gynaecologists, UK.关于抗-D预防的共识会议声明。1997年4月7日和8日。英国爱丁堡皇家内科医学院、皇家妇产科学院。
Vox Sang. 1998;74(2):127-8. doi: 10.1046/j.1423-0410.1998.7420127.x.
Zotero 插件